
#104: Frazis Capital Partners Update
Sep 14, 2026 - 00:26:24
Radio and PodcastLive Radio & Podcasts
Syntara’s highly anticipated Phase 2 results in myelofibrosis—what the data tells us, why the market sold off, and what might come next in terms of funding or partnership.